Listing of Color Additives Exempt From Certification; Spirulina Extract, 49117-49120 [2013-19550]
Download as PDF
Federal Register / Vol. 78, No. 156 / Tuesday, August 13, 2013 / Rules and Regulations
The Rule
This action amends Title 14 Code of
Federal Regulations (14 CFR) Part 71 by
modifying Class E airspace extending
upward from 700 feet above the surface
at Brigham City Airport, Brigham City,
UT. The segment from the 4.3-mile
radius of the airport extends to 9.4 miles
southwest of the airport instead of 7
miles from the NDB, keeping the same
footprint. Decommissioning of the
Brigham City NDB has made this action
necessary, and enhances the safety and
management of aircraft operations. The
geographic coordinates of the airport are
updated to coincide with the FAA’s
aeronautical database.
The FAA has determined this
regulation only involves an established
body of technical regulations for which
frequent and routine amendments are
necessary to keep them operationally
current. Therefore, this regulation: (1) Is
not a ‘‘significant regulatory action’’
under Executive Order 12866; (2) is not
a ‘‘significant rule’’ under DOT
Regulatory Policies and Procedures (44
FR 11034; February 26, 1979); and (3)
does not warrant preparation of a
regulatory evaluation as the anticipated
impact is so minimal. Since this is a
routine matter that only affects air traffic
procedures and air navigation, it is
certified this rule, when promulgated,
does not have a significant economic
impact on a substantial number of small
entities under the criteria of the
Regulatory Flexibility Act. The FAA’s
authority to issue rules regarding
aviation safety is found in Title 49 of the
U.S. Code. Subtitle 1, Section 106
discusses the authority of the FAA
Administrator. Subtitle VII, Aviation
Programs, describes in more detail the
scope of the agency’s authority. This
rulemaking is promulgated under the
authority described in Subtitle VII, Part
A, Subpart I, Section 40103. Under that
section, the FAA is charged with
prescribing regulations to assign the use
of airspace necessary to ensure the
safety of aircraft and the efficient use of
airspace. This regulation is within the
scope of that authority as it modifies
controlled airspace at Brigham City
Airport, Brigham City, UT.
ehiers on DSK2VPTVN1PROD with RULES
Environmental Review
15:29 Aug 12, 2013
Jkt 229001
The Food and Drug
Administration (FDA or we) is
amending the color additive regulations
to provide for the safe use of spirulina
extract made from the dried biomass of
the cyanobacteria Arthrospira platensis
(A. platensis), as a color additive in
candy and chewing gum. This action is
in response to a petition filed by Mars,
Inc.
SUMMARY:
List of Subjects in 14 CFR Part 71
Airspace, Incorporation by reference,
Navigation (air).
Adoption of the Amendment
In consideration of the foregoing, the
Federal Aviation Administration
amends 14 CFR part 71 as follows:
PART 71—DESIGNATION OF CLASS A,
B, C, D AND E AIRSPACE AREAS; AIR
TRAFFIC SERVICE ROUTES; AND
REPORTING POINTS
1. The authority citation for 14 CFR
Part 71 continues to read as follows:
This rule is effective September
13, 2013. See section X for related
information on the filing of objections.
Submit either electronic or written
objections and requests for a hearing by
September 12, 2013.
ADDRESSES:
■
Authority: 49 U.S.C. 106(g), 40103, 40113,
40120; E.O. 10854, 24 FR 9565, 3 CFR, 1959–
1963 Comp., p. 389.
§ 71.1
[Amended]
2. The incorporation by reference in
14 CFR 71.1 of the Federal Aviation
Administration Order 7400.9W,
Airspace Designations and Reporting
Points, dated August 8, 2012, and
effective September 15, 2012 is
amended as follows:
■
Paragraph 6005 Class E airspace areas
extending upward from 700 feet or more
above the surface of the earth.
*
*
*
*
*
ANM UT E5 Brigham City, UT [Modified]
Brigham City Airport, UT
(Lat. 41°33′16″ N., long. 112°03′44″ W.)
That airspace extending upward from 700
feet above the surface within a 4.3-mile
radius of the Brigham City Airport, and
within 4 miles each side of the 205° bearing
of the Brigham City Airport extending from
the 4.3-mile radius to 9.4 miles southwest of
the airport.
Issued in Seattle, Washington, on August 2,
2013.
Christopher Ramirez,
Acting Manager, Operations Support Group,
Western Service Center.
[FR Doc. 2013–19464 Filed 8–12–13; 8:45 am]
BILLING CODE 4910–13–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
The FAA has determined that this
action qualifies for categorical exclusion
under the National Environmental
Policy Act in accordance with FAA
Order 1050.1E, ‘‘Environmental
Impacts: Policies and Procedures,’’
paragraph 311a. This airspace action is
not expected to cause any potentially
significant environmental impacts, and
no extraordinary circumstances exist
VerDate Mar<15>2010
that warrant preparation of an
environmental assessment.
49117
21 CFR Part 73
[Docket No. FDA–2011–C–0878]
Food and Drug Administration,
HHS.
ACTION:
PO 00000
Final rule.
Frm 00009
Fmt 4700
You may submit written or
electronic objections and requests for a
hearing, identified by Docket No. FDA–
2011–C–0878, by any of the following
methods:
Electronic Submissions
Submit electronic objections in the
following way:
• Federal eRulemaking Portal: https://
www.regulations.gov. Follow the
instructions for submitting comments.
Written Submissions
Submit written objections in the
following ways:
• Mail/Hand delivery/Courier (for
paper or CD–ROM submissions):
Division of Dockets Management (HFA–
305), Food and Drug Administration,
5630 Fishers Lane, Rm. 1061, Rockville,
MD 20852.
Instructions: All submissions received
must include the Agency name and
Docket No. FDA–2011–C–0878 for this
rulemaking. All objections received will
be posted without change to https://
www.regulations.gov, including any
personal information provided. For
detailed instructions on submitting
objections, see the ‘‘Objections’’ heading
of the SUPPLEMENTARY INFORMATION
section of this document.
Docket: For access to the docket to
read background documents or
objections received, go to https://
www.regulations.gov and insert the
docket number(s), found in brackets in
the heading of this document, into the
‘‘Search’’ box and follow the prompts
and/or go to the Division of Dockets
Management, 5630 Fishers Lane, Rm.
1061, Rockville, MD 20852.
FOR FURTHER INFORMATION CONTACT:
Listing of Color Additives Exempt
From Certification; Spirulina Extract
AGENCY:
DATES:
Felicia M. Ellison, Center for Food
Safety and Applied Nutrition (HFS–
265), Food and Drug Administration,
5100 Paint Branch Pkwy., College Park,
MD 20740–3835, 240–402–1264.
SUPPLEMENTARY INFORMATION:
Sfmt 4700
E:\FR\FM\13AUR1.SGM
13AUR1
49118
Federal Register / Vol. 78, No. 156 / Tuesday, August 13, 2013 / Rules and Regulations
I. Introduction
In a document published in the
Federal Register of January 20, 2012 (77
FR 2935), we announced that Mars, Inc.,
c/o Keller and Heckman LLP, 1001 G
Street NW., Suite 500 West,
Washington, DC 20001, had filed a color
additive petition (CAP 2C0293). The
petition proposed to amend the color
additive regulations in part 73 Listing of
Color Additives Exempt From
Certification (21 CFR part 73) to provide
for the safe use of spirulina blue, an
extract made from the biomass of A.
platensis, as a color additive in candy
and chewing gum. We are establishing
spirulina extract as the common or
usual name for this color additive
instead of the proposed name spirulina
blue because it more appropriately
describes the additive.
ehiers on DSK2VPTVN1PROD with RULES
II. Identity, Manufacturing, and
Specifications
The color additive that is the subject
of this petition is a concentrated
aqueous extract from the dried biomass
of the cyanobacteria A. platensis, also
called spirulina. Spirulina is a bluegreen filamentous cyanobacteria that
occurs naturally in freshwater and
marine habitats. It has a long history as
a food in many countries (Ref. 1).
Spirulina contains chlorophyll and
phycobilins, which absorb sunlight and
have a role in photosynthesis. The
phycobilins found in spirulina are
phycocyanins, which are blue and,
together with chlorophyll, give spirulina
its characteristic blue-green color.
The petitioner describes the
manufacture of spirulina extract using
the species A. platensis. Spirulina
extract consists primarily of the water
soluble components of spirulina,
namely phycocyanins and other
proteins, polysaccharides, lipids, and
minor amounts of components such as
vitamins, minerals, and moisture. In
general, spirulina extract is
manufactured as follows: (1) The
spirulina biomass is obtained from
grown, harvested, rinsed, washed, and
spray dried spirulina; (2) the spirulina
biomass is soaked in water to extract the
water-soluble proteins; (3) the aqueous
extract is filtered and stabilized; and (4)
the stabilized filtrate is the color
additive spirulina extract. The spirulina
extract manufactured by the petitioner
contains not less than 10 percent
phycocyanins. We have determined that
because the amount of the color additive
used in food is self-limiting, there is no
need for a specific upper limit for the
color additive or phycocyanin content
(Ref. 2). Therefore, we are limiting the
use of spirulina extract in candy and
VerDate Mar<15>2010
15:29 Aug 12, 2013
Jkt 229001
chewing gum to amounts consistent
with good manufacturing practice. In
addition to specification limits for lead,
arsenic, and mercury, we are requiring
that the color additive be negative for
microcystin toxin, which is produced by
some species of cyanobacteria that
could be potentially present in the water
where A. platensis is grown and
harvested.
III. Evaluation of Safety
Under section 721(b)(4) of the Federal
Food, Drug, and Cosmetic Act (the
FD&C Act) (21 U.S.C. 379e(b)(4)), a color
additive may not be listed for a
particular use unless the data and
information available to FDA establishes
that the color additive is safe for that
use. Our color additive regulations at 21
CFR 70.3(i) define safe to mean that
there is ‘‘convincing evidence that
establishes with reasonable certainty
that no harm will result from the
intended use of the color additive.’’ To
establish with reasonable certainty that
a color additive intended for use in food
is not harmful under its intended
conditions of use, we consider the
projected human dietary exposure to the
additive, the additive’s toxicological
data, and other relevant information
(such as published literature) available
to us. We compare an individual’s
estimated daily intake (EDI) of the
additive from all food sources to an
acceptable intake level established by
toxicological data. The EDI is
determined by projections based on the
amount of the additive proposed for use
in particular foods and on data
regarding the amount consumed from
all food sources of the additive. We
commonly use the EDI for the 90th
percentile consumer of a color additive
as a measure of high chronic dietary
intake.
IV. Safety of Petitioned Use of the
Additive
We have previously considered the
safety of the dried biomass of spirulina
and certain spirulina-derived substances
in food as a result of submissions from
firms who have made their own
determinations that certain uses of
spirulina and spirulina-derived
substances in food are generally
recognized as safe (GRAS). Under
section 201(s) of the FD&C Act (21
U.S.C. 321(s)), a substance is GRAS if it
is generally recognized, among experts
qualified by scientific training and
experience to evaluate its safety, as
having been adequately shown through
scientific procedures (or, in the case of
a substance used in food before January
1, 1958, through either scientific
procedures or experience based on
PO 00000
Frm 00010
Fmt 4700
Sfmt 4700
common use in food) to be safe under
the conditions of its intended use.
Under section 201(s) of the FD&C Act,
a substance that is GRAS for a particular
use in food is not a food additive, and
may lawfully be utilized for that use
without our review and approval. There
is no GRAS exemption, however, to the
definition of color additive in section
201(t) of the FD&C Act (21 U.S.C.
321(t)). Therefore, we must approve the
use of a color additive in food before it
is marketed; otherwise the food
containing the color additive is
adulterated under section 402(c) of the
FD&C Act (21 U.S.C. 342(c)).
A firm may voluntarily submit
information on a GRAS selfdetermination to us for review through
our GRAS notification program (see 62
FR 18938 (April 17, 1997)). Through
this program, we have received four
GRAS notices (GRNs) for various uses of
spirulina and spirulina-derived
substances in food (GRNs 127, 394, 417,
and 424).1 We evaluated each of these
GRNs and concluded that we had no
reason to question the basis of the
notifier’s (a person who submits a GRAS
notice) GRAS determinations (Refs. 3 to
6). In particular, the spirulina substance
that was the subject of GRN 424 is
similar in chemical composition to the
subject color additive, with
phycocyanin content ranging from 42 to
47 percent.
Importantly, in our response to these
GRAS notifications, we indicated that if
the substances that were the subject of
these submissions impart color to the
food, they may be subject to regulation
as a color additive.
For the petitioned use of spirulina
extract to color candy and chewing gum,
we focused our review primarily on the
safety of the phycocyanins because
1 GRN 127 pertains to the use of the powdered
dried biomass of A. platensis as an ingredient in
specialty food bars, powdered nutritional drink
mixes, popcorn, and as a condiment in salads, at
levels ranging from 0.5 to 3.0 grams per serving.
GRN 394 pertains to the use of the powdered dried
biomass of A. platensis in certain fruit juices, low
calorie fruit and vegetable juice drinks at a level up
to 0.3 percent of the food, and in medical foods at
a level up to 1.25 percent. GRN 417 pertains to the
use of powdered dried biomass of A. platensis in
nonalcoholic beverages and beverage bases,
breakfast cereals, fruit juices, frozen dairy desserts
and mixes, grain products and pastas, milk
products, plant protein products, processed
vegetables and vegetable juices, snack foods, soft
candy, and soups and soup mixes, at levels ranging
from 0.5 to 3.0 grams per serving. Lastly, GRN 424
pertains to the use of an aqueous extract of
powdered A. platensis or A. maxima as an
ingredient for use in all foods at levels consistent
with good manufacturing practice, except for infant
formula and those (e.g., meat, eggs and catfish)
requiring additional review by the U.S. Department
of Agriculture. FDA also is aware that spirulinaderived substances are used as dietary ingredients
in dietary supplements.
E:\FR\FM\13AUR1.SGM
13AUR1
ehiers on DSK2VPTVN1PROD with RULES
Federal Register / Vol. 78, No. 156 / Tuesday, August 13, 2013 / Rules and Regulations
these pigments are the main coloring
components of the additive. As part of
our safety evaluation, we estimated the
exposure to phycocyanins from current
and proposed food uses of spirulinaderived ingredients. We estimate that
the petitioned use of spirulina extract in
candy and chewing gum will result in
an exposure to phycocyanins of 171
milligrams/person/day (mg/p/d) for the
90th percentile consumer 2 years of age
or older. Because children typically
consume more candy and chewing gum
than the general population, we
estimated the exposure to phycocyanins
from the petitioned use of the subject
color additive for children 2 to 5 and 6
to 12 years of age. For these population
subgroups, we estimate the exposure at
the 90th percentile to be 130 mg/p/d
and 185 mg/p/d, respectively. For a
cumulative exposure estimate, we used
exposure information from GRN 424.
The notifier for GRN 424 estimated a
conservative exposure to phycocyanins
from the notified uses of a spirulina
extract to be 1140 mg/p/d. This
exposure estimate does not include
exposure to spirulina and phycocyanins
from dietary supplement use due to the
belief that their use is not widespread,
and, therefore, would not significantly
contribute to the dietary exposure of the
wider population. (Ref. 7)
We have concluded that the exposure
that was estimated for GRN 424
represents the upper bound cumulative
exposure to phycocyanins from
spirulina-based ingredients in food
because of the high phycocyanin
content of the substance that is the
subject of GRN 424 (i.e., 42 to 47
percent) and its intended use in most
foods (including candy and chewing
gum). We conclude that this cumulative
exposure estimate of 1140 mg/p/d for
phycocyanins from current and
proposed uses of spirulina-derived
ingredients is sufficiently conservative
(Ref. 7).
To support the safety of the petitioned
use of the subject color additive in
candy and chewing gum, the petitioner
provided a number of published studies
that investigated the toxicity of various
spirulina powder extracts. The results of
these studies showed no toxic effects at
the doses that were tested. From these
studies, we selected, as the pivotal
safety study for this color additive, a
chronic feeding study that tested
spirulina powder in rats for 21 months
at concentrations of 10, 20, or 30
percent of the diet (equal to 5,000,
10,000 or 15,000 milligrams per
kilogram bodyweight per day (mg/kg
bw/day). We determined that the results
of this study showed no indications of
adverse effects in rats with prolonged
VerDate Mar<15>2010
15:29 Aug 12, 2013
Jkt 229001
consumption of the spirulina powder at
any of the doses tested. Therefore, we
concluded that the no-observed-effectlevel (NOEL) for spirulina based on the
highest dose tested in this study is
15,000 mg/kg bw/d (900,000 mg/p/d for
a 60 kilogram person). The phycocyanin
content in the spirulina powders that
were tested in this study were reported
to be in the range of 12 to 20.5 percent
and, based on this range, we have
determined the NOEL for phycocyanins
for humans to be between 108,000 to
184,500 mg/p/d. Taking into account
the available safety information, the
estimated intake of phycocyanins from
the petitioned use of the spirulina
extract, and the large margin of safety
between the cumulative EDI and the
NOEL, we conclude that the proposed
use of spirulina extract to color candy
and chewing gum is safe (Ref. 8).
We also evaluated the potential
allergenicity of spirulina extract. We
reviewed a comparison of the known
amino acid sequences of phycocyanins
with the sequences of known protein
allergens and determined that there is a
low probability that the phycocyanins
are protein allergens. We conclude that
spirulina phycocyanins present an
insignificant allergy risk to consumers
of the color additive.
Our conclusion regarding the safety of
the petitioned use of the color additive
is strengthened by the fact that the
phycocyanobilin chromophore (the part
of the molecule responsible for the
coloring effect of the additive) is similar
to certain bile pigments that are
excreted from the liver via the gall
bladder into the intestines. Based on a
literature search and review, none of the
bile pigments has been reported to
produce any toxic effect, except in
diseases caused by their presence in the
blood due to inborn error of metabolism
or other cause.
V. Conclusion
Based on the data and information in
the petition and other relevant material,
we conclude that the petitioned use of
spirulina extract, a color additive made
from the biomass of A. platensis, in
candy and chewing gum is safe. We
further conclude that the additive will
achieve its intended technical effect and
is suitable for the petitioned use.
Consequently, we are amending the
color additive regulations in part 73. In
addition, based upon the factors listed
in 21 CFR 71.20(b), we conclude that
certification of spirulina extract is not
necessary for the protection of the
public health.
PO 00000
Frm 00011
Fmt 4700
Sfmt 4700
49119
VI. Public Disclosure
In accordance with § 71.15 (21 CFR
71.15), the petition and the documents
that we considered and relied upon in
reaching our decision to approve the
petition will be made available for
public disclosure (see FOR FURTHER
INFORMATION CONTACT). As provided in
§ 71.15, we will delete from the
documents any materials that are not
available for public disclosure.
VII. Environmental Impact
We have previously considered the
environmental effects of this rule as
announced in the notice of filing for
CAP 2C0293 (77 FR 2935). No new
information or comments have been
received that would affect our previous
determination that there is no
significant impact on the human
environment and that an environmental
impact statement is not required.
VIII. Paperwork Reduction Act of 1995
This final rule contains no collection
of information. Therefore, clearance by
the Office of Management and Budget
under the Paperwork Reduction Act of
1995 is not required.
IX. Section 301(ll) of the FD&C Act
Our review of this petition was
limited to section 721 of the FD&C Act.
This final rule is not a statement
regarding compliance with other
sections of the FD&C Act. For example,
the Food and Drug Administration
Amendments Act of 2007, which was
signed into law on September 27, 2007,
amended the FD&C Act to, among other
things, add section 301(ll) of the FD&C
Act (21 U.S.C. 331(ll)). Section 301(ll) of
the FD&C Act prohibits the introduction
or delivery for introduction into
interstate commerce of any food that
contains a drug approved under section
505 of the FD&C Act (21 U.S.C. 355), a
biological product licensed under
section 351 of the Public Health Service
Act (42 U.S.C. 262), or a drug or
biological product for which substantial
clinical investigations have been
instituted and their existence has been
made public, unless one of the
exemptions in section 301(ll)(1) to (ll)(4)
of the FD&C Act applies. In our review
of this petition, we did not consider
whether section 301(ll) of the FD&C Act
or any of its exemptions apply to food
products containing this color additive.
Accordingly, this final rule should not
be construed to be a statement that a
product containing this color additive, if
introduced or delivered for introduction
into interstate commerce, would not
violate section 301(ll) of the FD&C Act.
Furthermore, this language is included
in all color additive final rules that
E:\FR\FM\13AUR1.SGM
13AUR1
49120
Federal Register / Vol. 78, No. 156 / Tuesday, August 13, 2013 / Rules and Regulations
pertain to food and therefore should not
be construed to be a statement of the
likelihood that section 301(ll) of the
FD&C Act applies.
X. Objections
This rule is effective as shown in the
section of this document; except
as to any provisions that may be stayed
by the filing of proper objections. Any
person who will be adversely affected
by this regulation may file with the
Division of Dockets Management (see
ADDRESSES) either electronic or written
objections. Each objection shall be
separately numbered, and each
numbered objection shall specify with
particularity the provisions of the
regulation to which objection is made
and the grounds for the objection. Each
numbered objection on which a hearing
is requested shall specifically so state.
Failure to request a hearing for any
particular objection shall constitute a
waiver of the right to a hearing on that
objection. Each numbered objection for
which a hearing is requested shall
include a detailed description and
analysis of the specific factual
information intended to be presented in
support of the objection in the event
that a hearing is held. Failure to include
such a description and analysis for any
particular objection shall constitute a
waiver of the right to a hearing on the
objection. It is only necessary to send
one set of documents. Identify
documents with the docket number
found in brackets in the heading of this
document. Any objections received in
response to the regulation may be seen
in the Division of Dockets Management
between 9 a.m. and 4 p.m., Monday
through Friday. We will publish notice
of the objections that we have received
or lack thereof in the Federal Register.
DATES
XI. References
ehiers on DSK2VPTVN1PROD with RULES
The following references have been
placed on display in the Division of
Dockets Management (see ADDRESSES)
and may be seen by interested persons
between 9 a.m. and 4 p.m., Monday
through Friday, and are available
electronically at https://
www.regulations.gov. (FDA has verified
the Web site addresses, but FDA is not
responsible for any subsequent changes
to Web sites after this document
publishes in the Federal Register.)
1. M. A. B. Habib, M. Parvin, T. C.
Huntington, and M. R. Hasan. 2008. ‘‘A
Review on Culture, Production and Use
of Spirulina as Food for Humans and
Feeds for Domestic Animals and Fish.’’
FAO Fisheries and Aquaculture Circular
No. 1034. Rome, FAO (ftp://ftp.fao.org/
docrep/fao/011/i0424e/i0424e00.pdf).
VerDate Mar<15>2010
15:29 Aug 12, 2013
Jkt 229001
2. Memorandum from N. Belai, Color
Technology Team, OCAC, CFSAN, FDA
to F. Ellison, Division of Petition Review,
OFAS, CFSAN, FDA, December 12, 2012.
3. Letter from L. Tarantino, Office of Food
Additive Safety, CFSAN, FDA to J. Dore,
Cyanotech Corporation, Agency
Response Letter GRAS Notice No. GRN
000127, October 6, 2003, (https://
www.fda.gov/Food/
IngredientsPackagingLabeling/GRAS/
NoticeInventory/ucm153944.htm).
4. Letter from D. Keefe, Office of Food
Additive Safety, CFSAN, FDA to S. Cho,
Nutra Source, Agency Response Letter
GRAS Notice No. GRN 000394, June 4,
2012, (https://www.fda.gov/Food/
IngredientsPackagingLabeling/GRAS/
NoticeInventory/ucm313046.htm).
5. Letter from D. Keefe, Office of Food
Additive Safety, CFSAN, FDA to J.
Endres, AIBMR Life Sciences, Inc.,
Agency Response Letter GRAS Notice
No. GRN 000417, August 10, 2012,
(https://www.fda.gov/Food/
IngredientsPackagingLabeling/GRAS/
NoticeInventory/ucm319628.htm).
6. Letter from D. Keefe, Office of Food
Additive Safety, CFSAN, FDA to H.
Newman, Desert Lake Technologies,
LLC, Agency Response Letter GRAS
Notice No. GRN 000424, December 6,
2012, (https://www.fda.gov/Food/
IngredientsPackagingLabeling/GRAS/
NoticeInventory/ucm335743.htm).
7. Memorandum from D. Folmer, Division of
Petition Review, CFSAN, FDA to F.
Ellison, Division of Petition Review,
CFSAN, FDA, May 31, 2012.
8. Memorandum from G. Erives, Division of
Petition Review, CFSAN, FDA to F.
Ellison, Division of Petition Review,
CFSAN, FDA, October 2, 2012.
List of Subjects in 21 CFR Part 73
Color additives, Cosmetics, Drugs,
Medical devices.
Therefore, under the Federal Food,
Drug, and Cosmetic Act and under
authority delegated to the Commissioner
of Food and Drugs, and redelegated to
the Director, Center for Food Safety and
Applied Nutrition, 21 CFR part 73 is
amended as follows:
PART 73—LISTING OF COLOR
ADDITIVES EXEMPT FROM
CERTIFICATION
1. The authority citation for 21 CFR
part 73 continues to read as follows:
■
(2) Color additive mixtures for food
use made with spirulina extract may
contain only those diluents that are
suitable and are listed in this subpart as
safe for use in color additive mixtures
for coloring foods.
(b) Specifications. Spirulina extract
must conform to the following
specifications and must be free from
impurities, other than those named, to
the extent that such other impurities
may be avoided by good manufacturing
practice:
(1) Lead, not more than 2 milligrams
per kilogram (mg/kg) (2 part per million
(ppm));
(2) Arsenic, not more than 2 mg/kg (2
ppm);
(3) Mercury, not more than 1 mg/kg (1
ppm); and
(4) Negative for microcystin toxin.
(c) Uses and restrictions. Spirulina
extract may be safely used for coloring
candy and chewing gum at levels
consistent with good manufacturing
practice, except that it may not be used
to color foods for which standards of
identity have been issued under section
401 of the Federal Food, Drug, and
Cosmetic Act, unless the use of the
added color is authorized by such
standards.
(d) Labeling requirements. The label
of the color additive and of any mixture
prepared therefrom intended solely or
in part for coloring purposes must
conform to § 70.25 of this chapter.
(e) Exemption from certification.
Certification of this color additive is not
necessary for the protection of the
public health, and therefore batches
thereof are exempt from the certification
requirements of section 721(c) of the
Federal Food, Drug, and Cosmetic Act.
Dated: August 6, 2013.
Susan M. Bernard,
Director, Office of Regulations, Policy and
Social Sciences, Center for Food Safety and
Applied Nutrition.
[FR Doc. 2013–19550 Filed 8–12–13; 8:45 am]
BILLING CODE 4160–01–P
DEPARTMENT OF THE INTERIOR
Bureau of Indian Affairs
Authority: 21 U.S.C. 321, 341, 342, 343,
348, 351, 352, 355, 361, 362, 371, 379e.
25 CFR Part 11
2. Add § 73.530 to subpart A to read
as follows:
[BIA–2013–0001; 134/A0J351010.999900/
AAKL008000]
§ 73.530
RIN 1076–AF16
■
Spirulina extract.
(a) Identity. (1) The color additive
spirulina extract is prepared by the
filtered aqueous extraction of the dried
biomass of Arthrospira platensis. The
color additive contains phycocyanins as
the principal coloring components.
PO 00000
Frm 00012
Fmt 4700
Sfmt 4700
Courts of Indian Offenses
Bureau of Indian Affairs,
Interior.
ACTION: Final rule.
AGENCY:
E:\FR\FM\13AUR1.SGM
13AUR1
Agencies
[Federal Register Volume 78, Number 156 (Tuesday, August 13, 2013)]
[Rules and Regulations]
[Pages 49117-49120]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-19550]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
21 CFR Part 73
[Docket No. FDA-2011-C-0878]
Listing of Color Additives Exempt From Certification; Spirulina
Extract
AGENCY: Food and Drug Administration, HHS.
ACTION: Final rule.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA or we) is amending the
color additive regulations to provide for the safe use of spirulina
extract made from the dried biomass of the cyanobacteria Arthrospira
platensis (A. platensis), as a color additive in candy and chewing gum.
This action is in response to a petition filed by Mars, Inc.
DATES: This rule is effective September 13, 2013. See section X for
related information on the filing of objections. Submit either
electronic or written objections and requests for a hearing by
September 12, 2013.
ADDRESSES: You may submit written or electronic objections and requests
for a hearing, identified by Docket No. FDA-2011-C-0878, by any of the
following methods:
Electronic Submissions
Submit electronic objections in the following way:
Federal eRulemaking Portal: https://www.regulations.gov.
Follow the instructions for submitting comments.
Written Submissions
Submit written objections in the following ways:
Mail/Hand delivery/Courier (for paper or CD-ROM
submissions): Division of Dockets Management (HFA-305), Food and Drug
Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.
Instructions: All submissions received must include the Agency name
and Docket No. FDA-2011-C-0878 for this rulemaking. All objections
received will be posted without change to https://www.regulations.gov,
including any personal information provided. For detailed instructions
on submitting objections, see the ``Objections'' heading of the
SUPPLEMENTARY INFORMATION section of this document.
Docket: For access to the docket to read background documents or
objections received, go to https://www.regulations.gov and insert the
docket number(s), found in brackets in the heading of this document,
into the ``Search'' box and follow the prompts and/or go to the
Division of Dockets Management, 5630 Fishers Lane, Rm. 1061, Rockville,
MD 20852.
FOR FURTHER INFORMATION CONTACT: Felicia M. Ellison, Center for Food
Safety and Applied Nutrition (HFS-265), Food and Drug Administration,
5100 Paint Branch Pkwy., College Park, MD 20740-3835, 240-402-1264.
SUPPLEMENTARY INFORMATION:
[[Page 49118]]
I. Introduction
In a document published in the Federal Register of January 20, 2012
(77 FR 2935), we announced that Mars, Inc., c/o Keller and Heckman LLP,
1001 G Street NW., Suite 500 West, Washington, DC 20001, had filed a
color additive petition (CAP 2C0293). The petition proposed to amend
the color additive regulations in part 73 Listing of Color Additives
Exempt From Certification (21 CFR part 73) to provide for the safe use
of spirulina blue, an extract made from the biomass of A. platensis, as
a color additive in candy and chewing gum. We are establishing
spirulina extract as the common or usual name for this color additive
instead of the proposed name spirulina blue because it more
appropriately describes the additive.
II. Identity, Manufacturing, and Specifications
The color additive that is the subject of this petition is a
concentrated aqueous extract from the dried biomass of the
cyanobacteria A. platensis, also called spirulina. Spirulina is a blue-
green filamentous cyanobacteria that occurs naturally in freshwater and
marine habitats. It has a long history as a food in many countries
(Ref. 1). Spirulina contains chlorophyll and phycobilins, which absorb
sunlight and have a role in photosynthesis. The phycobilins found in
spirulina are phycocyanins, which are blue and, together with
chlorophyll, give spirulina its characteristic blue-green color.
The petitioner describes the manufacture of spirulina extract using
the species A. platensis. Spirulina extract consists primarily of the
water soluble components of spirulina, namely phycocyanins and other
proteins, polysaccharides, lipids, and minor amounts of components such
as vitamins, minerals, and moisture. In general, spirulina extract is
manufactured as follows: (1) The spirulina biomass is obtained from
grown, harvested, rinsed, washed, and spray dried spirulina; (2) the
spirulina biomass is soaked in water to extract the water-soluble
proteins; (3) the aqueous extract is filtered and stabilized; and (4)
the stabilized filtrate is the color additive spirulina extract. The
spirulina extract manufactured by the petitioner contains not less than
10 percent phycocyanins. We have determined that because the amount of
the color additive used in food is self-limiting, there is no need for
a specific upper limit for the color additive or phycocyanin content
(Ref. 2). Therefore, we are limiting the use of spirulina extract in
candy and chewing gum to amounts consistent with good manufacturing
practice. In addition to specification limits for lead, arsenic, and
mercury, we are requiring that the color additive be negative for
microcystin toxin, which is produced by some species of cyanobacteria
that could be potentially present in the water where A. platensis is
grown and harvested.
III. Evaluation of Safety
Under section 721(b)(4) of the Federal Food, Drug, and Cosmetic Act
(the FD&C Act) (21 U.S.C. 379e(b)(4)), a color additive may not be
listed for a particular use unless the data and information available
to FDA establishes that the color additive is safe for that use. Our
color additive regulations at 21 CFR 70.3(i) define safe to mean that
there is ``convincing evidence that establishes with reasonable
certainty that no harm will result from the intended use of the color
additive.'' To establish with reasonable certainty that a color
additive intended for use in food is not harmful under its intended
conditions of use, we consider the projected human dietary exposure to
the additive, the additive's toxicological data, and other relevant
information (such as published literature) available to us. We compare
an individual's estimated daily intake (EDI) of the additive from all
food sources to an acceptable intake level established by toxicological
data. The EDI is determined by projections based on the amount of the
additive proposed for use in particular foods and on data regarding the
amount consumed from all food sources of the additive. We commonly use
the EDI for the 90th percentile consumer of a color additive as a
measure of high chronic dietary intake.
IV. Safety of Petitioned Use of the Additive
We have previously considered the safety of the dried biomass of
spirulina and certain spirulina-derived substances in food as a result
of submissions from firms who have made their own determinations that
certain uses of spirulina and spirulina-derived substances in food are
generally recognized as safe (GRAS). Under section 201(s) of the FD&C
Act (21 U.S.C. 321(s)), a substance is GRAS if it is generally
recognized, among experts qualified by scientific training and
experience to evaluate its safety, as having been adequately shown
through scientific procedures (or, in the case of a substance used in
food before January 1, 1958, through either scientific procedures or
experience based on common use in food) to be safe under the conditions
of its intended use. Under section 201(s) of the FD&C Act, a substance
that is GRAS for a particular use in food is not a food additive, and
may lawfully be utilized for that use without our review and approval.
There is no GRAS exemption, however, to the definition of color
additive in section 201(t) of the FD&C Act (21 U.S.C. 321(t)).
Therefore, we must approve the use of a color additive in food before
it is marketed; otherwise the food containing the color additive is
adulterated under section 402(c) of the FD&C Act (21 U.S.C. 342(c)).
A firm may voluntarily submit information on a GRAS self-
determination to us for review through our GRAS notification program
(see 62 FR 18938 (April 17, 1997)). Through this program, we have
received four GRAS notices (GRNs) for various uses of spirulina and
spirulina-derived substances in food (GRNs 127, 394, 417, and 424).\1\
We evaluated each of these GRNs and concluded that we had no reason to
question the basis of the notifier's (a person who submits a GRAS
notice) GRAS determinations (Refs. 3 to 6). In particular, the
spirulina substance that was the subject of GRN 424 is similar in
chemical composition to the subject color additive, with phycocyanin
content ranging from 42 to 47 percent.
---------------------------------------------------------------------------
\1\ GRN 127 pertains to the use of the powdered dried biomass of
A. platensis as an ingredient in specialty food bars, powdered
nutritional drink mixes, popcorn, and as a condiment in salads, at
levels ranging from 0.5 to 3.0 grams per serving. GRN 394 pertains
to the use of the powdered dried biomass of A. platensis in certain
fruit juices, low calorie fruit and vegetable juice drinks at a
level up to 0.3 percent of the food, and in medical foods at a level
up to 1.25 percent. GRN 417 pertains to the use of powdered dried
biomass of A. platensis in nonalcoholic beverages and beverage
bases, breakfast cereals, fruit juices, frozen dairy desserts and
mixes, grain products and pastas, milk products, plant protein
products, processed vegetables and vegetable juices, snack foods,
soft candy, and soups and soup mixes, at levels ranging from 0.5 to
3.0 grams per serving. Lastly, GRN 424 pertains to the use of an
aqueous extract of powdered A. platensis or A. maxima as an
ingredient for use in all foods at levels consistent with good
manufacturing practice, except for infant formula and those (e.g.,
meat, eggs and catfish) requiring additional review by the U.S.
Department of Agriculture. FDA also is aware that spirulina-derived
substances are used as dietary ingredients in dietary supplements.
---------------------------------------------------------------------------
Importantly, in our response to these GRAS notifications, we
indicated that if the substances that were the subject of these
submissions impart color to the food, they may be subject to regulation
as a color additive.
For the petitioned use of spirulina extract to color candy and
chewing gum, we focused our review primarily on the safety of the
phycocyanins because
[[Page 49119]]
these pigments are the main coloring components of the additive. As
part of our safety evaluation, we estimated the exposure to
phycocyanins from current and proposed food uses of spirulina-derived
ingredients. We estimate that the petitioned use of spirulina extract
in candy and chewing gum will result in an exposure to phycocyanins of
171 milligrams/person/day (mg/p/d) for the 90th percentile consumer 2
years of age or older. Because children typically consume more candy
and chewing gum than the general population, we estimated the exposure
to phycocyanins from the petitioned use of the subject color additive
for children 2 to 5 and 6 to 12 years of age. For these population
subgroups, we estimate the exposure at the 90th percentile to be 130
mg/p/d and 185 mg/p/d, respectively. For a cumulative exposure
estimate, we used exposure information from GRN 424. The notifier for
GRN 424 estimated a conservative exposure to phycocyanins from the
notified uses of a spirulina extract to be 1140 mg/p/d. This exposure
estimate does not include exposure to spirulina and phycocyanins from
dietary supplement use due to the belief that their use is not
widespread, and, therefore, would not significantly contribute to the
dietary exposure of the wider population. (Ref. 7)
We have concluded that the exposure that was estimated for GRN 424
represents the upper bound cumulative exposure to phycocyanins from
spirulina-based ingredients in food because of the high phycocyanin
content of the substance that is the subject of GRN 424 (i.e., 42 to 47
percent) and its intended use in most foods (including candy and
chewing gum). We conclude that this cumulative exposure estimate of
1140 mg/p/d for phycocyanins from current and proposed uses of
spirulina-derived ingredients is sufficiently conservative (Ref. 7).
To support the safety of the petitioned use of the subject color
additive in candy and chewing gum, the petitioner provided a number of
published studies that investigated the toxicity of various spirulina
powder extracts. The results of these studies showed no toxic effects
at the doses that were tested. From these studies, we selected, as the
pivotal safety study for this color additive, a chronic feeding study
that tested spirulina powder in rats for 21 months at concentrations of
10, 20, or 30 percent of the diet (equal to 5,000, 10,000 or 15,000
milligrams per kilogram bodyweight per day (mg/kg bw/day). We
determined that the results of this study showed no indications of
adverse effects in rats with prolonged consumption of the spirulina
powder at any of the doses tested. Therefore, we concluded that the no-
observed-effect-level (NOEL) for spirulina based on the highest dose
tested in this study is 15,000 mg/kg bw/d (900,000 mg/p/d for a 60
kilogram person). The phycocyanin content in the spirulina powders that
were tested in this study were reported to be in the range of 12 to
20.5 percent and, based on this range, we have determined the NOEL for
phycocyanins for humans to be between 108,000 to 184,500 mg/p/d. Taking
into account the available safety information, the estimated intake of
phycocyanins from the petitioned use of the spirulina extract, and the
large margin of safety between the cumulative EDI and the NOEL, we
conclude that the proposed use of spirulina extract to color candy and
chewing gum is safe (Ref. 8).
We also evaluated the potential allergenicity of spirulina extract.
We reviewed a comparison of the known amino acid sequences of
phycocyanins with the sequences of known protein allergens and
determined that there is a low probability that the phycocyanins are
protein allergens. We conclude that spirulina phycocyanins present an
insignificant allergy risk to consumers of the color additive.
Our conclusion regarding the safety of the petitioned use of the
color additive is strengthened by the fact that the phycocyanobilin
chromophore (the part of the molecule responsible for the coloring
effect of the additive) is similar to certain bile pigments that are
excreted from the liver via the gall bladder into the intestines. Based
on a literature search and review, none of the bile pigments has been
reported to produce any toxic effect, except in diseases caused by
their presence in the blood due to inborn error of metabolism or other
cause.
V. Conclusion
Based on the data and information in the petition and other
relevant material, we conclude that the petitioned use of spirulina
extract, a color additive made from the biomass of A. platensis, in
candy and chewing gum is safe. We further conclude that the additive
will achieve its intended technical effect and is suitable for the
petitioned use. Consequently, we are amending the color additive
regulations in part 73. In addition, based upon the factors listed in
21 CFR 71.20(b), we conclude that certification of spirulina extract is
not necessary for the protection of the public health.
VI. Public Disclosure
In accordance with Sec. 71.15 (21 CFR 71.15), the petition and the
documents that we considered and relied upon in reaching our decision
to approve the petition will be made available for public disclosure
(see FOR FURTHER INFORMATION CONTACT). As provided in Sec. 71.15, we
will delete from the documents any materials that are not available for
public disclosure.
VII. Environmental Impact
We have previously considered the environmental effects of this
rule as announced in the notice of filing for CAP 2C0293 (77 FR 2935).
No new information or comments have been received that would affect our
previous determination that there is no significant impact on the human
environment and that an environmental impact statement is not required.
VIII. Paperwork Reduction Act of 1995
This final rule contains no collection of information. Therefore,
clearance by the Office of Management and Budget under the Paperwork
Reduction Act of 1995 is not required.
IX. Section 301(ll) of the FD&C Act
Our review of this petition was limited to section 721 of the FD&C
Act. This final rule is not a statement regarding compliance with other
sections of the FD&C Act. For example, the Food and Drug Administration
Amendments Act of 2007, which was signed into law on September 27,
2007, amended the FD&C Act to, among other things, add section 301(ll)
of the FD&C Act (21 U.S.C. 331(ll)). Section 301(ll) of the FD&C Act
prohibits the introduction or delivery for introduction into interstate
commerce of any food that contains a drug approved under section 505 of
the FD&C Act (21 U.S.C. 355), a biological product licensed under
section 351 of the Public Health Service Act (42 U.S.C. 262), or a drug
or biological product for which substantial clinical investigations
have been instituted and their existence has been made public, unless
one of the exemptions in section 301(ll)(1) to (ll)(4) of the FD&C Act
applies. In our review of this petition, we did not consider whether
section 301(ll) of the FD&C Act or any of its exemptions apply to food
products containing this color additive. Accordingly, this final rule
should not be construed to be a statement that a product containing
this color additive, if introduced or delivered for introduction into
interstate commerce, would not violate section 301(ll) of the FD&C Act.
Furthermore, this language is included in all color additive final
rules that
[[Page 49120]]
pertain to food and therefore should not be construed to be a statement
of the likelihood that section 301(ll) of the FD&C Act applies.
X. Objections
This rule is effective as shown in the DATES section of this
document; except as to any provisions that may be stayed by the filing
of proper objections. Any person who will be adversely affected by this
regulation may file with the Division of Dockets Management (see
ADDRESSES) either electronic or written objections. Each objection
shall be separately numbered, and each numbered objection shall specify
with particularity the provisions of the regulation to which objection
is made and the grounds for the objection. Each numbered objection on
which a hearing is requested shall specifically so state. Failure to
request a hearing for any particular objection shall constitute a
waiver of the right to a hearing on that objection. Each numbered
objection for which a hearing is requested shall include a detailed
description and analysis of the specific factual information intended
to be presented in support of the objection in the event that a hearing
is held. Failure to include such a description and analysis for any
particular objection shall constitute a waiver of the right to a
hearing on the objection. It is only necessary to send one set of
documents. Identify documents with the docket number found in brackets
in the heading of this document. Any objections received in response to
the regulation may be seen in the Division of Dockets Management
between 9 a.m. and 4 p.m., Monday through Friday. We will publish
notice of the objections that we have received or lack thereof in the
Federal Register.
XI. References
The following references have been placed on display in the
Division of Dockets Management (see ADDRESSES) and may be seen by
interested persons between 9 a.m. and 4 p.m., Monday through Friday,
and are available electronically at https://www.regulations.gov. (FDA
has verified the Web site addresses, but FDA is not responsible for any
subsequent changes to Web sites after this document publishes in the
Federal Register.)
1. M. A. B. Habib, M. Parvin, T. C. Huntington, and M. R. Hasan.
2008. ``A Review on Culture, Production and Use of Spirulina as Food
for Humans and Feeds for Domestic Animals and Fish.'' FAO Fisheries
and Aquaculture Circular No. 1034. Rome, FAO (ftp://ftp.fao.org/docrep/fao/011/i0424e/i0424e00.pdf).
2. Memorandum from N. Belai, Color Technology Team, OCAC, CFSAN, FDA
to F. Ellison, Division of Petition Review, OFAS, CFSAN, FDA,
December 12, 2012.
3. Letter from L. Tarantino, Office of Food Additive Safety, CFSAN,
FDA to J. Dore, Cyanotech Corporation, Agency Response Letter GRAS
Notice No. GRN 000127, October 6, 2003, (https://www.fda.gov/Food/IngredientsPackagingLabeling/GRAS/NoticeInventory/ucm153944.htm).
4. Letter from D. Keefe, Office of Food Additive Safety, CFSAN, FDA
to S. Cho, Nutra Source, Agency Response Letter GRAS Notice No. GRN
000394, June 4, 2012, (https://www.fda.gov/Food/IngredientsPackagingLabeling/GRAS/NoticeInventory/ucm313046.htm).
5. Letter from D. Keefe, Office of Food Additive Safety, CFSAN, FDA
to J. Endres, AIBMR Life Sciences, Inc., Agency Response Letter GRAS
Notice No. GRN 000417, August 10, 2012, (https://www.fda.gov/Food/IngredientsPackagingLabeling/GRAS/NoticeInventory/ucm319628.htm).
6. Letter from D. Keefe, Office of Food Additive Safety, CFSAN, FDA
to H. Newman, Desert Lake Technologies, LLC, Agency Response Letter
GRAS Notice No. GRN 000424, December 6, 2012, (https://www.fda.gov/Food/IngredientsPackagingLabeling/GRAS/NoticeInventory/ucm335743.htm).
7. Memorandum from D. Folmer, Division of Petition Review, CFSAN,
FDA to F. Ellison, Division of Petition Review, CFSAN, FDA, May 31,
2012.
8. Memorandum from G. Erives, Division of Petition Review, CFSAN,
FDA to F. Ellison, Division of Petition Review, CFSAN, FDA, October
2, 2012.
List of Subjects in 21 CFR Part 73
Color additives, Cosmetics, Drugs, Medical devices.
Therefore, under the Federal Food, Drug, and Cosmetic Act and under
authority delegated to the Commissioner of Food and Drugs, and
redelegated to the Director, Center for Food Safety and Applied
Nutrition, 21 CFR part 73 is amended as follows:
PART 73--LISTING OF COLOR ADDITIVES EXEMPT FROM CERTIFICATION
0
1. The authority citation for 21 CFR part 73 continues to read as
follows:
Authority: 21 U.S.C. 321, 341, 342, 343, 348, 351, 352, 355,
361, 362, 371, 379e.
0
2. Add Sec. 73.530 to subpart A to read as follows:
Sec. 73.530 Spirulina extract.
(a) Identity. (1) The color additive spirulina extract is prepared
by the filtered aqueous extraction of the dried biomass of Arthrospira
platensis. The color additive contains phycocyanins as the principal
coloring components.
(2) Color additive mixtures for food use made with spirulina
extract may contain only those diluents that are suitable and are
listed in this subpart as safe for use in color additive mixtures for
coloring foods.
(b) Specifications. Spirulina extract must conform to the following
specifications and must be free from impurities, other than those
named, to the extent that such other impurities may be avoided by good
manufacturing practice:
(1) Lead, not more than 2 milligrams per kilogram (mg/kg) (2 part
per million (ppm));
(2) Arsenic, not more than 2 mg/kg (2 ppm);
(3) Mercury, not more than 1 mg/kg (1 ppm); and
(4) Negative for microcystin toxin.
(c) Uses and restrictions. Spirulina extract may be safely used for
coloring candy and chewing gum at levels consistent with good
manufacturing practice, except that it may not be used to color foods
for which standards of identity have been issued under section 401 of
the Federal Food, Drug, and Cosmetic Act, unless the use of the added
color is authorized by such standards.
(d) Labeling requirements. The label of the color additive and of
any mixture prepared therefrom intended solely or in part for coloring
purposes must conform to Sec. 70.25 of this chapter.
(e) Exemption from certification. Certification of this color
additive is not necessary for the protection of the public health, and
therefore batches thereof are exempt from the certification
requirements of section 721(c) of the Federal Food, Drug, and Cosmetic
Act.
Dated: August 6, 2013.
Susan M. Bernard,
Director, Office of Regulations, Policy and Social Sciences, Center for
Food Safety and Applied Nutrition.
[FR Doc. 2013-19550 Filed 8-12-13; 8:45 am]
BILLING CODE 4160-01-P